C9293 HCPCS code: Injection, glucarpidase, 10 units
C9293 is the HCPCS Level II code for injection, glucarpidase, 10 units. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 700 per day on outpatient hospital claims.
Code details
| Field | Value |
|---|---|
| Section | C codes — Outpatient PPS (hospital outpatient temporary codes) |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 53 |
| BETOS category | O1E — Other drugs |
| Added | 2012-10-01 |
| Last action effective | 2024-01-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 700 | Prescribing Information |
| practitioner claims | 700 | Prescribing Information |
What changed for C9293
- 2012-10-01: C9293 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code C9293?
C9293 is the HCPCS Level II code for injection, glucarpidase, 10 units. Short descriptor: "Injection, glucarpidase".
Does Medicare cover C9293?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of C9293 can be billed per day?
700 on outpatient hospital claims; 700 on practitioner claims (NCCI medically unlikely edits).
Related C92 codes
- C9248 — Injection, clevidipine butyrate, 1 mg
- C9250 — Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
- C9254 — Injection, lacosamide, 1 mg
- C9257 — Injection, bevacizumab, 0.25 mg
- C9275 — Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
- C9285 — Lidocaine 70 mg/tetracaine 70 mg, per patch
- C9290 — Injection, bupivacaine liposome, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under C9293
- Watch C9293 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for C9293
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.